Latest Leonhardt Ventures Stories
First implantable pump for timed dosed repeat delivery of stem cells and growth factors SANTA MONICA, Calif., Jan. 22, 2014 /PRNewswire/ -- BioLeonhardt, a Leonhardt Ventures company based in Los Angeles, will unveil its implantable Stem Cell Pump at the 9th Annual Cell Therapy for Cardiovascular Disease meeting at Columbia University in New York on Thursday, January 23, 2014 at 10:30 am. BioLeonhardt - Has developed a programmable implantable stem cell infusion pump and electrical stimulator...
- To talk saucily.
- Insolent, opprobrious language; impertinent abuse.